Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes

Summary

The aim of the study is to assess the efficacy of 17-hydroxyprogesterone caproate (17P) therapy on the latency period in pregnant women with Preterm premature rupture of membranes.

Timeline

Start

2018-01-10

Primary completion

2020-10-10

Completion

2020-12-10

Drugs

Indications